Understanding
MIRA AI
Your complete guide to understanding how MIRA AI assists medical professionals in breast cancer detection. Explore the technology, learn about the science behind it, and discover why accessible healthcare matters.
What is MIRA AI?
Understanding how technology helps doctors in the fight against breast cancer.
MIRA AI = Mammographic Image Recognition & Analysis
An intelligent system designed to assist doctors and radiologists in detecting breast cancer from mammogram images using affordable hardware and powerful AI.
Making advanced AI-powered screening accessible to everyone, bridging the gap between traditional X-ray films and modern digital analysis.
Very Fast Analysis
AI-assisted analysis in seconds
Privacy First
All processing happens locally
High Accuracy
Trained on thousands of examples
Neural Networking
Deep learning AI architecture
Breast Cancer Awareness
Understanding breast cancer, breaking the stigma, and why accessible healthcare technology matters for everyone.
Women worldwide diagnosed with breast cancer in their lifetime
New breast cancer cases diagnosed globally each year
Survival rate when proper diagnosis and treatment is accessible
Let's Talk About It
Breast cancer is not something to be ashamed of. It affects millions worldwide. By talking openly about breast health, we encourage proper medical attention and support those going through diagnosis and treatment. Knowledge reduces fear. Support matters.
Why MIRA AI Matters
Technology in service of humanity
Democratizing Healthcare
Affordable AI-powered analysis for all facilities
Supporting Professionals
A second pair of eyes for radiologists
How MIRA AI Works
A step-by-step look at how physical mammograms are analyzed using artificial intelligence.
★What Makes MIRA AI Unique
Unlike traditional digital mammography systems, MIRA AI works with physical X-ray films — bringing AI analysis to hospitals that still use traditional film-based mammography, without requiring expensive equipment upgrades.
The Complete Workflow
Detection
Ultrasonic sensor detects when a mammogram is placed on the lightbox
Illumination
LED lightbox automatically turns on to illuminate the mammogram
Capture
High-resolution camera takes a precise photo of the mammogram
Analysis
AI model processes the image and looks for potential issues
Result
Doctor receives the analysis with confidence score on the dashboard
Detection
Ultrasonic sensor detects when a mammogram is placed on the lightbox
Illumination
LED lightbox automatically turns on to illuminate the mammogram
Capture
High-resolution camera takes a precise photo of the mammogram
Analysis
AI model processes the image and looks for potential issues
Result
Doctor receives the analysis with confidence score on the dashboard
The Hardware
Explore the physical components that make MIRA AI possible. Each part plays a vital role in the imaging and analysis process.
Dual-core ESP32 microcontrollers coordinate sensors, camera, and lighting seamlessly.
1600×1200 UXGA resolution captures every detail of mammogram films with precision.
Ultrasonic sensors automatically trigger capture when a film is placed on the lightbox.
Custom IoT hardware stack designed for affordability and accessibility. Each component plays a vital role in the automated mammogram imaging pipeline, from detection to capture.
How the AI Thinks
Understanding the machine learning model that powers MIRA AI's analysis capabilities.
The Secret: Transfer Learning
MIRA AI uses ResNet101 — a 101-layer neural network pre-trained on millions of images. Instead of learning from scratch, it applies existing pattern recognition knowledge to mammograms. This makes training faster and more accurate with less data.
How Was It Trained?
Gathering Examples
Trained on CBIS-DDSM dataset with thousands of real mammograms
Data Augmentation
Creates variations of images to improve pattern recognition
Learning from Mistakes
The AI adjusts after seeing millions of examples
Validation & Testing
Tested on completely new images it has never seen
Training Configuration
Understanding the Results
What the analysis means and how doctors use this information to help patients.
BENIGN
Not Cancerous
The AI did not detect signs of cancer in the mammogram. Tissue appears normal or contains non-cancerous growths. Regular follow-up screenings may still be recommended.
MALIGNANT
Potentially Cancerous
Patterns commonly associated with cancerous tissue were detected. This does NOT confirm cancer — it means further investigation is recommended. Many flagged cases are benign after further testing.
What Appears on the Dashboard
Information Displayed
Processing Timeline
Disclaimer
Important information about the proper use and limitations of MIRA AI.
Medical Disclaimer
MIRA AI is intended solely as a decision-support research tool. It is designed to demonstrate the potential of artificial intelligence in medical imaging analysis. This system does not provide medical advice, diagnosis, or treatment recommendations. Always seek the guidance of qualified health providers with any questions you may have regarding a medical condition.
Not a Medical Device
MIRA AI is a research and educational project, not a certified medical device. It has not been approved or cleared by any regulatory health authority (such as FDA, CE, or equivalent) for clinical diagnostic use. The system should never be used as the sole basis for making medical decisions about patient care, treatment, or diagnosis.
Professional Oversight Required
Any analysis provided by MIRA AI must be reviewed, verified, and interpreted by qualified healthcare professionals — radiologists, oncologists, or other licensed medical practitioners. AI systems, regardless of their sophistication, cannot replace the clinical judgment, experience, and expertise of trained medical professionals who consider the full context of a patient's health history.
Consult Your Doctor
If you have concerns about breast health or have received mammogram results (from MIRA AI or any other source), please consult with a qualified healthcare provider immediately. Only a licensed medical professional can provide accurate medical advice, proper diagnosis, and appropriate treatment recommendations based on comprehensive clinical evaluation.
Limitations of AI
Artificial intelligence systems have inherent limitations. MIRA AI may produce incorrect results, miss certain abnormalities, or indicate false positives. Factors like image quality, lighting conditions, film quality, and database representation during training can all affect accuracy. The confidence scores provided are statistical estimates, not guarantees of correctness.
Why We Include This Disclaimer
We believe deeply in the potential of technology to improve healthcare accessibility. However, we also recognize the immense responsibility that comes with developing tools that interact with medical decision-making. Including this disclaimer is not just a legal formality — it reflects our genuine commitment to ethical technology development.
Healthcare decisions affect real lives. A missed diagnosis can delay life-saving treatment. A false positive can cause unnecessary anxiety and invasive procedures. We want MIRA AI to be part of the solution, not a source of confusion or harm. That's why we emphasize that our system should always be used alongside, never instead of, professional medical expertise.
AI is a tool, not a replacement for human judgment. The best outcomes in healthcare come from combining the pattern-recognition capabilities of AI with the contextual understanding, empathy, and clinical experience of human healthcare providers. We built MIRA AI to support this collaboration, not to undermine it.
Transparency builds trust. By being upfront about what MIRA AI can and cannot do, we hope to foster informed conversations about the role of AI in medicine. We encourage users, healthcare providers, and patients to approach all AI-assisted analysis with appropriate curiosity and healthy skepticism.
If you have questions about MIRA AI, its development, or appropriate use cases, please reach out to the development team. We are committed to responsible innovation and welcome feedback from healthcare professionals, researchers, and the community.
Return to Homepage